<unk> , sold under the brand name Dutrebis, is a fixed-dose combination antiretroviral medication used in the treatment of HIV/AIDS. It contains<unk>  and<unk> . It is taken by mouth. Side effects may include lactic acidosis, pancreatitis, liver failure, and severe skin rashes. It was approved for medical use in the United States in 2015.<unk>  is not available in the United States.
Lamivudine/raltegravir
Abacavir/lamivudine
Lamivudine/tenofovir
Atazanavir/ritonavir
Lamivudine/zidovudine
Dolutegravir/lamivudine
Dolutegravir/rilpivirine
Cabotegravir/rilpivirine